Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Bowden

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biochimica Et Biophysica Acta|October 13, 1992
Immunochemical characterisation of parathyroid hormone-related protein from tumour and non-tumour cellsJ F Emly, W A Ratcliffe, E Green, et al.
The Journal of Endocrinology|August 1, 1994
Parathyroid hormone-related protein in human term placenta and membranesS J Bowden, J F Emly, S V Hughes, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 27, 2018
Feasibility of Dose-escalated Hypofractionated Chemoradiation in Human Papilloma Virus-negative or Smoking-associated Oropharyngeal CancerS Meade, P Gaunt, A Hartley, et al.
Clinical Endocrinology|May 1, 1994
Expression and processing of parathyroid hormone-related protein in a pancreatic endocrine cell tumour associated with hypercalcaemiaW A Ratcliffe, S J Bowden, F P Dunne, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 21, 2021
Morbidity after local excision of the transformation zone for cervical intra-epithelial neoplasia and early cervical cancerM Kyrgiou, S J Bowden, A Athanasiou, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 3, 2023
Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose IntensityI N Fernando, S Lax, S J Bowden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2014
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patientsH R Ali, E Provenzano, S-J Dawson, et al.
British Journal of Cancer|October 11, 2012
Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trialsH M Earl, L Hiller, J A Dunn, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biochimica Et Biophysica Acta|October 13, 1992
Immunochemical characterisation of parathyroid hormone-related protein from tumour and non-tumour cellsJ F Emly, W A Ratcliffe, E Green, et al.
The Journal of Endocrinology|August 1, 1994
Parathyroid hormone-related protein in human term placenta and membranesS J Bowden, J F Emly, S V Hughes, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 27, 2018
Feasibility of Dose-escalated Hypofractionated Chemoradiation in Human Papilloma Virus-negative or Smoking-associated Oropharyngeal CancerS Meade, P Gaunt, A Hartley, et al.
Clinical Endocrinology|May 1, 1994
Expression and processing of parathyroid hormone-related protein in a pancreatic endocrine cell tumour associated with hypercalcaemiaW A Ratcliffe, S J Bowden, F P Dunne, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 21, 2021
Morbidity after local excision of the transformation zone for cervical intra-epithelial neoplasia and early cervical cancerM Kyrgiou, S J Bowden, A Athanasiou, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 3, 2023
Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose IntensityI N Fernando, S Lax, S J Bowden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2014
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patientsH R Ali, E Provenzano, S-J Dawson, et al.
British Journal of Cancer|October 11, 2012
Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trialsH M Earl, L Hiller, J A Dunn, et al.
Pageof 2